Cornerstone Therapeutics acquires Cardiokine Inc.

Cornerstone Therapeutics, a specialty pharmaceutical company focused on acquiring, developing and commercializing proprietary products for the hospital and respiratory markets, announced that it has acquired Cardiokine Inc., a specialty pharmaceutical company focused on developing hospital products for cardiovascular indications. The merger was effective Dec. 30, 2011.

If you have any questions about the merger, please contact Josh Franklin at (919) 678-6520.